Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Dec;98(4):1287–1295. doi: 10.1111/j.1476-5381.1989.tb12676.x

Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase.

M Goppelt-Struebe 1, D Wolter 1, K Resch 1
PMCID: PMC1854794  PMID: 2514948

Abstract

1. Prostanoid synthesis was induced in bone marrow-derived macrophages by addition of exogenous arachidonic acid to the cell cultures. When the cells were preincubated with dexamethasone (10(-7) and 10(-6) M) overnight, prostaglandin synthesis was inhibited by 66.5 +/- 2.8% and 56.7 +/- 2.9% (mean +/- s.d.; n = 3) respectively. 2. Endogenous membrane bound phospholipase A2 was measured with labelled phospholipids used as substrates. The enzyme activity with phosphatidylcholine and phosphatidylethanolamine as substrates was inhibited by 27.0 +/- 8.3% and 23.3 +/- 11.1% (n = 4) respectively, in dexamethasone-treated macrophages compared to control cells. Neither the distribution of radiolabelled arachidonic acid among the different phospholipid species nor the release of arachidonic acid from prelabelled cells were significantly impaired by pretreatment of the macrophages with dexamethasone (1 microM). 3. The enzyme activity of the cyclo-oxygenase/prostaglandin E (PGE) isomerase was measured in cell membranes from control cells and dexamethasone-treated cells. It was inhibited by 40.0 +/- 8.4% (n = 4) in dexamethasone-treated cells as compared to control cells. Thus, glucocorticoids inhibit not only phospholipase A2 in these cells, but predominantly inhibit arachidonic acid metabolism subsequent to its release from phospholipids.

Full text

PDF
1287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarsman A. J., Mynbeek G., van den Bosch H., Rothhut B., Prieur B., Comera C., Jordan L., Russo-Marie F. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent. FEBS Lett. 1987 Jul 13;219(1):176–180. doi: 10.1016/0014-5793(87)81212-7. [DOI] [PubMed] [Google Scholar]
  2. Bailey J. M., Makheja A. N., Pash J., Verma M. Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1159–1163. doi: 10.1016/s0006-291x(88)80995-1. [DOI] [PubMed] [Google Scholar]
  3. Calignano A., Carnuccio R., Di Rosa M., Ialenti A., Moncada S. The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins. Agents Actions. 1985 Mar;16(1-2):60–62. doi: 10.1007/BF01999650. [DOI] [PubMed] [Google Scholar]
  4. Davidson F. F., Dennis E. A., Powell M., Glenney J. R., Jr Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem. 1987 Feb 5;262(4):1698–1705. [PubMed] [Google Scholar]
  5. Erman A., Hassid A., Baer P. G., Nasjletti A. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats. J Pharmacol Exp Ther. 1986 Oct;239(1):296–301. [PubMed] [Google Scholar]
  6. Fan T. P., Lewis G. P. Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages. Prostaglandins. 1985 Nov;30(5):735–747. doi: 10.1016/0090-6980(85)90004-8. [DOI] [PubMed] [Google Scholar]
  7. Flesch I., Ferber E. Effect of cellular fatty acid composition on the phospholipase A2 activity of bone marrow-derived macrophages, and their ability to induce lucigenin-dependent chemiluminescence. Biochim Biophys Acta. 1986 Oct 31;889(1):6–14. doi: 10.1016/0167-4889(86)90003-0. [DOI] [PubMed] [Google Scholar]
  8. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  9. Flower R. J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988 Aug;94(4):987–1015. doi: 10.1111/j.1476-5381.1988.tb11614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Foster S. J., McCormick M. E. The mechanism of the anti-inflammatory activity of glucocorticosteroids. Agents Actions. 1985 Mar;16(1-2):58–59. doi: 10.1007/BF01999649. [DOI] [PubMed] [Google Scholar]
  11. Glenney J. R., Jr, Tack B., Powell M. A. Calpactins: two distinct Ca++-regulated phospholipid- and actin-binding proteins isolated from lung and placenta. J Cell Biol. 1987 Mar;104(3):503–511. doi: 10.1083/jcb.104.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goppelt-Struebe M., Koerner C. F., Hausmann G., Gemsa D., Resch K. Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins. 1986 Sep;32(3):373–385. doi: 10.1016/0090-6980(86)90006-7. [DOI] [PubMed] [Google Scholar]
  13. Goppelt M., Resch K. Densitometric quantitation of individual phospholipids from natural sources separated by one-dimensional thin-layer chromatography. Anal Biochem. 1984 Jul;140(1):152–156. doi: 10.1016/0003-2697(84)90146-5. [DOI] [PubMed] [Google Scholar]
  14. Goud T. J., Schotte C., van Furth R. Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. J Exp Med. 1975 Nov 1;142(5):1180–1199. doi: 10.1084/jem.142.5.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. doi: 10.1073/pnas.73.5.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Huang K. S., Wallner B. P., Mattaliano R. J., Tizard R., Burne C., Frey A., Hession C., McGray P., Sinclair L. K., Chow E. P. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase. Cell. 1986 Jul 18;46(2):191–199. doi: 10.1016/0092-8674(86)90736-1. [DOI] [PubMed] [Google Scholar]
  18. Hullin F., Raynal P., Ragab-Thomas J. M., Fauvel J., Chap H. Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis. J Biol Chem. 1989 Feb 25;264(6):3506–3513. [PubMed] [Google Scholar]
  19. Hutton J. C. Calcium-binding proteins and secretion. Cell Calcium. 1986 Dec;7(5-6):339–352. doi: 10.1016/0143-4160(86)90037-0. [DOI] [PubMed] [Google Scholar]
  20. Ichikawa Y., Pluznik D. H., Sachs L. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A. 1966 Aug;56(2):488–495. doi: 10.1073/pnas.56.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Isacke C. M., Lindberg R. A., Hunter T. Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids. Mol Cell Biol. 1989 Jan;9(1):232–240. doi: 10.1128/mcb.9.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kaever V., Goppelt-Strübe M., Resch K. Enhancement of eicosanoid synthesis in mouse peritoneal macrophages by the organic mercury compound thimerosal. Prostaglandins. 1988 Jun;35(6):885–902. doi: 10.1016/0090-6980(88)90114-1. [DOI] [PubMed] [Google Scholar]
  23. Koehler L., Hass R., Goppelt-Struebe M., Kaever V., Resch K. Differential effect of dexamethasone on the regulation of phospholipase A2 and prostanoid synthesis in undifferentiated and phorbolester-differentiated U937 cells. J Cell Biochem. 1989 Jul;40(3):397–406. doi: 10.1002/jcb.240400315. [DOI] [PubMed] [Google Scholar]
  24. Moore P. K., Hoult J. R. Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdown. Nature. 1980 Nov 20;288(5788):269–270. doi: 10.1038/288269a0. [DOI] [PubMed] [Google Scholar]
  25. Náray-Fejes-Tóth A., Fejes-Tóth G., Fischer C., Frölich J. C. Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest. 1984 Jul;74(1):120–123. doi: 10.1172/JCI111391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Parente L., Di Rosea M., Flower R. J., Ghiara P., Meli R., Persico P., Salmon J. A., Wood J. N. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol. 1984 Mar 23;99(2-3):233–239. doi: 10.1016/0014-2999(84)90246-2. [DOI] [PubMed] [Google Scholar]
  27. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1657–1661. doi: 10.1073/pnas.86.5.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Resch K., Imm W., Ferber E., Wallach D. F., Fischer H. Quantitative determination of soluble and membrane proteins through their native fluorescence. Naturwissenschaften. 1971 Apr;58(4):220–220. doi: 10.1007/BF00591853. [DOI] [PubMed] [Google Scholar]
  29. Robin J. L., Seldin D. C., Austen K. F., Lewis R. A. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J Immunol. 1985 Oct;135(4):2719–2726. [PubMed] [Google Scholar]
  30. Rosenkrantz B., Náray-Fejes-Tóth A., Fejes-Tóth G., Fischer C., Sawada M., Frölich J. C. Dexamethasone effect on prostanoid formation in healthy man. Clin Sci (Lond) 1985 Jun;68(6):681–685. doi: 10.1042/cs0680681. [DOI] [PubMed] [Google Scholar]
  31. Rothhut B., Comera C., Prieur B., Errasfa M., Minassian G., Russo-Marie F. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells. FEBS Lett. 1987 Jul 13;219(1):169–175. doi: 10.1016/0014-5793(87)81211-5. [DOI] [PubMed] [Google Scholar]
  32. Rousseau G. G. Control of gene expression by glucocorticoid hormones. Biochem J. 1984 Nov 15;224(1):1–12. doi: 10.1042/bj2240001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Russo-Marie F., Duval D. Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta. 1982 Jul 20;712(1):177–185. doi: 10.1016/0005-2760(82)90100-x. [DOI] [PubMed] [Google Scholar]
  34. Saris C. J., Tack B. F., Kristensen T., Glenney J. R., Jr, Hunter T. The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell. 1986 Jul 18;46(2):201–212. doi: 10.1016/0092-8674(86)90737-3. [DOI] [PubMed] [Google Scholar]
  35. Sato E. F., Miyahara M., Utsumi K. Purification and characterization of a lipocortin-like 33 kDa protein from guinea pig neutrophils. FEBS Lett. 1988 Jan 25;227(2):131–135. doi: 10.1016/0014-5793(88)80883-4. [DOI] [PubMed] [Google Scholar]
  36. Scott W. A., Pawlowski N. A., Andreach M., Cohn Z. A. Resting macrophages produce distinct metabolites from exogenous arachidonic acid. J Exp Med. 1982 Feb 1;155(2):535–547. doi: 10.1084/jem.155.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  38. Wood J. N., Coote P. R., Rhodes J. Hydrocortisone inhibits prostaglandin production but not arachidonic acid release from cultured macrophages. FEBS Lett. 1984 Aug 20;174(1):143–146. doi: 10.1016/0014-5793(84)81093-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES